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ABSTRACT  The SAK cell  line, derived from a spontaneous thymic lymphoma in an AKR mouse, 
is  resistant to  lysis  by glucocorticoids  in  spite of  the  presence  of  functional  glucocorticoicl 
receptor.  Receptor function was determined  by hormone binding analyses, as well  as charac- 
terization of  hormonal  effects on  cell  growth  and on  the accumulation  of murine  leukemia 
virus  and  metallothionein  mRNAs.  SAK  cells  were  fused  with  a  receptor-defective  (and 
therefore  resistant)  variant of  a well-characterized  murine  thymoma  line, W7.  The  resulting 
hybrids are glucocorticoid sensitive, demonstrating complementation  of the receptor defect in 
W7 cells by the functional glucocorticoid receptor of SAK. This fusion shows that SAK cells are 
resistant to the hormone clue to the absence of another function designated 'T' for lysis. SAK 
cells  were also fused  with glucocorticoid-sensitive W7 cells  (containing wild-type receptor), 
generating  glucocorticoid-sensitive  hybrids, which  demonstrate  that the dexamethasone-re- 
sistant phenotype of the SAK cells  is recessive. Resistant derivatives of this hybrid were found 
which  still contain  the full  amount  of  receptor.  Chromosome  analysis  revealed  that, on  the 
average, the resistant  derivatives had  lost  two chromosomes,  suggesting segregation  of chro- 
mosomes carrying genetic material  necessary for the "lysis" function. 
The drug 5-azacytidine (a known  inhibitor of DNA methylation)  has been  shown to cause 
heritable  changes  in  gene  expression.  Treatment  of  SAK cells  with  5-azacytidine generated 
glucocorticoid-sensitive clones at high frequency, suggesting that the gene(s)  involved in the 
"lysis" function are intact and have been inactivated through a process such as differentiation. 
It has been known for over thirty years that T-lymphocytes, 
during early stages of differentiation,  are lysed by glucocorti- 
coid hormones. In addition, a number of neoplastic T-cell lines 
derived from both human (1) and mouse (2, 3) are sensitive to 
lysis by glucocorticoids (1--4). A  variety of mutagenic treat- 
ments  have  been  used  to  generate  dexamethasone-  (dex,  a 
synthetic glucocorticoid) resistant derivatives ofglucocorticoid- 
sensitive lymphoid cell lines in order to study the biology of 
the  lytic  response,  as  well  as  the  mechanism  of action  of 
glucocorticoids. Numerous studies have demonstrated that glu- 
cocorticoid receptor binding and  translocation of the steroid 
hormone into the nucleus are a necessary step for the response; 
further steps in the cytolytic pathway remain obscure (reviewed 
in references 5-7). In spite of considerable effort, no resistant 
variant  resulting  from a  defect in a  function other than  the 
receptor has ever been found (8, 9).  Moreover, complementa- 
tion  between  receptor-defective variants  has never  been ob- 
served (8, 10), indicating that all variants obtained so far result 
from defects in the same genetic locus. 
SAK  is  a  cell  line  derived  from  a  spontaneous  thymic 
lymphoma in  an  AKR/J  mouse.  SAK cells  do  not  lyse  in 
response to dex; instead,  the cells continue to grow and also 
form  aggregates.  This  report  provides  both  biological  and 
biochemical evidence that the glucocorticoid receptor in SAK 
cells  is functional.  The presence of functional glucocorticoid 
receptor in this dex-resistant  T-ceU line makes  it  possible  to 
use a genetic approach to begin to analyze other steps in the 
cytolytic pathway.  Genetic experiments  are  described  which 
show that at least one other function, in addition to hormone 
binding to the receptor, is required for the cytolytic response to 
glucocorticoids. Treatment of SAK cells with 5-azacytidine (an 
inhibitor of DNA methylation) causes this "lysis" function to 
be activated and results in a cytolytic response to glucocorti- 
coids.  Our  results  support  the  hypothesis  that  this  "lysis" 
function  is  inactivated  in  SAK cells  possibly  as  a  result  of 
differentiation.  Thus,  SAK cells  may provide a  model for a 
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into  this  mode  of acquisition  of glucocorticoid resistance  in 
vivo. 
MATERIALS  AND  METHODS 
Cell  Lines and  Culture  Conditions:  The  SAK  cell  line 
(SAKRTLS.12.1)  is a  cloned routine T-cell line derived from  a  spontaneous 
tumor in an AKR mouse. The SAK cells were a generous gift from Dr. Robert 
Hyman  (Salk  Institute).  Both  SAK  and  its subclone,  SAK8,  show  the  same 
properties with respect to glucocorticoid receptor and response. The  receptor- 
defective W7 variant used is Mouarl01a derived by M. Huet-Minkowski (Institut 
Pasteur) by treatment of W7TG with bleomycin to produce a receptorless variant 
which was then selected for ouabain resistance (8). This variant has been shown 
by Scatchard analysis to contain <10% of the amount of specific binding seen in 
the parent (data not shown) and is completely resistant to lysis. The W7  line 
containing two copies of the wild-type receptor locus, which was used in this 
work, is W7TGoua  r~ isolated by M. Pfahl (Salk Institute; l 1). All cell lines and 
hybrids were grown in Dulbecco's Modified Eagle's medium (DME) containing 
10% fetal calf serum (FCS) in a humidified atmosphere at 37°C. 
Steroid Binding Assays:  The binding of [3H]dex to whole cells and 
the nuclear transfer of the receptor-hormone complex were measured as described 
(12). 
Analysis of mRNA Accumulation:  The accumulation  of leukemia 
virus mRNA in SAK8 cells was measured by the method of Wahl et al. (13). 
Briefly,  oligo(dT)  cellulose columns  were  used  to  select poly(A)-containing 
mRNA. The mRNA was denatured with glyoxal, fractionated in a  1% agarose 
gel, transferred to nitrocellulose paper, and probed with Moloney leukemia virus 
cDNA (generously provided by Dr. Inder Verma, Sulk Institute). The nitrocel- 
lulose was washed and exposed to film. The  developed film was analyzed by 
scanning the bands which correspond to viral mRNA in an LKB densitometer 
(LKB Instruments, Broma, Sweden). The area under the peaks was compared to 
quantitate the increase in viral mRNA. 
Cell  Fusions and  Chromosome  Analysis:  Cell  fusions  were 
induced  by  polyethylene glycol and  carried  out  essentially as  described  by 
Davidson and Gerald (14). The W7 derivatives both carried a selectable marker 
(resistance to 6 thioguanine or bromodeoxyuridine) as well as resistance to 1-5 
mM  ouabain. Hybrids were selected in HAT  medium (15)  containing 1 mM 
ouahain. The DNA content of the hybrids was analyzed on the flow microfluor- 
imeter after staining the cells with chromomycin (16). 
The number of chromosomes in the hybrid clones was determined as described 
previously (4). 
5-Azacytidine Treatment:  Exponentially growing SAK8 cells were 
treated for 13 h with 3 #M 5-azacytidine (Calhiochem-Behring Corp., San Diego, 
CA). After extensive washing, the cells were allowed to recover until exponential 
growth had resumed (24-48 h), then subcloned at a dilution of 0.25 cells/well in 
tissue culture trays. Clones were picked 9 d later and screened for dex sensitivity. 
The cloning efficiency of the 5-azacytidine-treated cells is 30%-50%;  the cloning 
efficiency of untreated ceils is 100%. 
RESULTS 
Growth of SAK8 Cells in the Presence of Dex 
SAK8 cells normally grow in suspension  as single cells or 
small clumps  of three  to eight  cells  (Fig.  IA).  After 48  h  of 
culture in medium containing 5 x  10  -a M dexamethasone, the 
cells  do not lyse;  instead,  large aggregates  of up to  100 cells 
appear (Fig.  1 B). Such aggregates of cells are also seen in the 
presence  of  other  glucocorticoid  hormones  such  as  cortisol 
(data not shown). If the formation of the aggregates is specific 
for glucocorticoid hormones, it should be possible to prevent 
the  response  by  adding  an  excess  of  an  antiglucocorticoid 
compound. In the presence of 5 x  10  -6 M progesterone alone, 
a known antiglucocorticoid (17), the gross phenotypic charac- 
FIGURE  I  Growth  of SAK8 cells  in the absence and  presence of hormone.  SAK8 cells were cultured  as described  in Materials and 
Methods  for 4  d  in  the absence  (A)  or  presence  of the  following  hormones:  (B)  5  x  10  -a  M  dexamethasone,  (C)  5  x  10  6 M 
progesterone,  (D)  5 x  10  6 M  progesterone,  and 5 x  10  -a M  dexamethasone.  Magnifications  are the same  in  A-D. 
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shows that a  100-fold excess of progesterone (5 ×  10  -6 M) does 
in fact block the aggregation response to dex (5 x  10  -a M). 
In addition to the aggregation response,  SAK8 cells grow 
more  slowly  in  the  presence  of dex.  The  doubling  time  is 
increased from 12 h to ~18 h and the cultures reach a final cell 
density of 1 to  1.5 x  106 cells/ml rather than 2.5 to 3.5  ×  106 
ceUs/ml (refer to Fig. 7A). The ability of single cells to form 
clones  is  also  decreased  from  100% seen  in  the  absence  of 
hormone to between 20%  and 50% in  10  -6 M  dex. This inhi- 
bition in cloning efficiency is overcome by increasing the FCS 
from  10% to 20%,  conditions in which the cloning efficiency 
increases  to  between  70%  and  100%  of the  control.  These 
hormonal effects on cell doubling time and cloning efficiency 
could result from a decrease in growth factor production caused 
by glucocorticoid hormones.  Such an effect on growth factor 
production  has  been  described  in  mitogen-induced  T-cells 
where clonal expansion is inhibited by dex (18). 
These effects of dex on the grwoth of SAK8 cells indicate 
that, in spite of the absence of the cytolytic response, glucocor- 
ticoid hormones have specific effects mediated by functional 
glucocorticoid receptor. To confirm this observation, we turned 
to other, more biochemical approaches, to demonstrate func- 
tional hormone receptor in these cells. 
Glucocorticoid Receptor in SAK Cells 
Fig. 2 shows the Scatchard analysis (19) of [3H]dex-binding 
data from SAK cells and several hybrids generated from SAK 
(described in following sections). SAK cells contain approxi- 
mately 31,000 (mean +  SE =  30,700 _  2,800) glucocorticoid- 
binding sites per cell, with a dissociation constant of 10 nM for 
dex. In addition, nuclear transfer assays show that >60% of the 
receptor-hormone complexes are translocated into the nucleus 
(data not  shown).  The  results of the  Scatchard and  nuclear 
transfer analyses are very similar to the values obtained for the 
WEHI-7 (WT) cell line (4) and another AKR cell line (unpub- 
lished  observations),  both  of which  are  lysed  by  dex.  The 
hormone binding analyses used here have detected alterations 
in receptor number or nuclear transfer capacity of hundreds of 
W7  variant  clones  (8,  9)  which  are  resistant to  dex  due  to 
receptor  defects.  Thus,  abnormal  binding  of glucocorticoid 
hormone in SAK cells would be detectable by these procedures. 
Increased Accumulation of Specific mRNAs in 
the Presence of Dex 
The SAK8 cell line was derived from a spontaneous thymic 
lymphoma  in  an  AKR/J  mouse.  AKR/J  mice  have  stably 
integrated copies of murine leukemia virus (type C retrovirus) 
in their genome. Glucocorticoid hormones have been reported 
to enhance the synthesis of virus in an AKR mouse embryonic 
cell line (20) and other cell lines which express type C  retrovi- 
ruses (21, 22). Thus, it was of interest to determine whether the 
endogenous murine leukemia virus (MuLV) mRNA in SAK8 
cells was increased by dex, especially in view of the fact that 
we had seen an increase in synthesis of the viral gp70 envelope 
glycoprotein (23). 
RNA was prepared from SAK8 cells incubated in medium 
containing  10  -7  dex for 6  or 24 h.  Poly(A)-containing RNA 
was selected using oligo(dT) cellulose. Samples of untreated 
control mRNA as well as mRNA from dex-treated cells were 
fractionated in  an  agarose  gel,  transferred  to  nitrocellulose 
paper,  and  the transfer was probed with  Moloney leukemia 
virus cDNA. The hybridized blot was exposed to film, and the 
densitometric scan of the film was analyzed. Table I shows that 
the samples from the cells treated with dex for 6 or 24 h contain 
over threefold more mRNA that hybridized to the leukemia 
virus cDNA probe than the control. 
Work by Palmiter et al. (24) has shown that glucocorticoid 
hormones increase the levels of metailothionein mRNA in a 
variety of cell types. Metallothionein mRNA was quantitated 
by  solution hybridization (25)  using  nucleic acids extracted 
from untreated SAK8 cells and those grown in the presence of 
10  -6  M  dex  for  20  h.  Table  I  shows  a  2.5-fold  increase  in 
metallothionein  mRNA  molecules/ceil after  dex  treatment. 
This  induction is similar to  that  obtained  in  W7  cells after 
demethylation of the metallothionein gene by treatment of W7 
cells with 5-azacytidine (26).  The metallothionein gene is not 
expressed in W7 cells before treatment with 5-azacytidine. 
We have shown  that  both  MuLV  mRNA  and metailothi- 
onein mRNA levels are increased in SAK8 cells treated with 
dex. These results together with the effects of glucocorticoids 
on SAK8 growth and the dex binding assays leave little doubt 
that  SAK8  ceils contain  functional  glucocorticoid receptor. 
Therefore, SAK ceils must be resistant to lysis by glucocorticoid 
hormones because they lack another function involved in the 
cytolytic response. We have used a genetic approach to address 
the basis for glucocorticoid resistance in these cells. 
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FIGURE  2  Binding of [3H]dex to SAK cells and hybrids. The whole 
cell-binding assays were performed as described (12)  and the data 
was analyzed by the method of Scatchard (19). The data shown are 
those of one representative analysis. The mean number of receptor 
sites  and standard error calculated from at least three independent 
assays are given in the text: SAK  parent  (A);  hybrid  between SAK 
cells and the receptor-defective variant of W7  (0); hybrid between 
SAK  cells  and  the  W7  parent containing  wild  type  receptor  (x); 
resistant derivative of this  hybrid  (O).  In all cases the dissociation 
constant for dex was -10 nM. 
TABL[  I 
Effect of Dex on Specific mRNA  Levels 
Concentra-  Dex- 
tion of dex  Time  No dex  treated 
M  h 
MuLV  10  -7  6  1"  3.3 
24  1  3.2 
Metallothionein  10  -6  20  905  224 
PolyA  ÷  RNA  was  prepared  and  MuLV  mRNA  analyzed  as  described  in 
Materials and Methods. Metallothionein mRNA was assayed by R. Palmiter 
as described (personal communication; 25). 
*  Relative  units  as derived  from  densitometer  tracings  of  film  exposed  to 
Northern blot (see Materials and Methods). 
I: Units are molecules per cell. 
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To demonstrate the existence of another function involved 
in the cytolytic response, we fused SAK cells with a receptor- 
defective variant of the dex-sensitive W7 cell line.  Fig. 2 shows 
the Scatchard analysis of the [3H]dex-binding data from this 
hybrid.  The hybrid contains essentially  the same  number of 
sites  (27,100  +  1,800) with the same affinity for hormone as 
the SAK parent. This is the expected result since nearly all of 
the dex binding sites in the hybrid are contributed by the SAK 
cells.  After fusion, no appearance  of previously unexpressed 
hormone binding sites contributed by the W7 parent is seen. 
Fig. 3 shows the growth of the two parental cell lines and 
four hybrid clones in varying concentrations of dex. Both the 
parental lines and hybrid clones grow in the absence of hor- 
mone (top row), but only the two dex-resistant  parental lines 
grow in the presence of dex (10  -~ to  10  -6 M). The $AK line 
appears to have fewer cells in the presence of dex, due to cell 
aggregation  and  the  decreased  t'mal  cell  density  described 
above. The small white areas seen in the wells containing the 
hybrids in the presence of dex are cell debris. 
Fig. 4 shows growth curves of the SAK parent, the receptor- 
defective W7 parent and one of the hybrid clones in  10  -5 M 
dex. It is evident from the growth curve that the hybrid clone 
is killed  by dex while the two parental cell lines continue to 
grow.  Direct  microscopic observation  showed  that  all  seven 
hybrids derived from this fusion were lysed by alex. 
Since the defect conferring resistance to the W7 derivative is 
known to be the absence of glucocorticoid receptors (< 10% of 
the wild-type receptor number), the observed complementation 
(Figs. 3 and 4) demonstrates that the SAK line is resistant to 
lysis by dex because it lacks a function other than the receptor, 
designated  "1"  for lysis.  The  lysis  function  in  the  hybrid  is 
contributed  by the receptor-defective W7  variant,  and  func- 
tional receptor is contributed by the SAK parent. This comple- 
mentation can be expressed in the following simplified way: 
SAK (2r+/21 -)  ×  W7 (2r-/21 +)  ~  hybrid (2r+2r-/21+21-). 
dex-resistant  dex-resistant  dex-sensitive 
FIGURE  4  Kinetics  of  lysis 
in  a  hybrid"  cell  line. 
Growth  curves  were  per-  ,J  io  6 
formed  in  the  presence of  ~, 
I0 -s M  dex on the SAK  (X)  ,~  s 
and  receptor-defective W7 
(Ix) parents and one of the  .~ 
.3  hybrids  (©)  shown  in  Fig.  a 
3.  Living  cells  were  deter- 
mined  by  trypan  blue  ex- 
clusion  and  counted  in  a  i°~ 
hemocytometer. 
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FIGURE  3  Complementation  between two dex  r cell  lines. Parental cell lines (SAK and W7)  and four independently arisen hybrids 
were inoculated  into a 24-well  tissue culture  tray at a cell density of I0  s cells/ml.  The molar concentration  of dex is indicated  for 
each row. The cells were allowed to grow for 4 d  before the tray was photographed. The white areas are generated by the presence 
of cells or cellular debris. 
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receptor locus and 1  + indicates the presence of the lysis function 
which may be encoded by one or several loci. 
Segregation  of the Lysis Function 
Since  intraspecies  hybrids  have  been  shown  to  segregate 
chromosomes (10, 27, 28), we wished to obtain hybrid deriva- 
tives which had become dex resistant through the loss of the 
'T' function, while retaining the full amount of receptor. We 
constructed another type of hybrid containing four copies of 
the glucocorticoid receptor, but only two copies of the func- 
tional "lysis" locus or loci, in order to favor segregation of the 
"l" function. We fused SAK cells with dex-sensitive W7 cells 
which contain 30,000 glucooorticoid receptors per cell to pro- 
duce hybrids tetraploid for the receptor. All six hybrids tested 
had between 50,000 and 60,000 receptors per cell. One hybrid 
with 50,900 (+3,600)  receptors per cell (Fig. 2) was used for 
further studies. The number of receptor sites should approach 
60,000 sites/cell (the sum of the receptor contents of SAK and 
W7). However, previous reports have shown that in parental 
fusions between W7 lines, some variability in the number of 
receptor sites of hybrid clones is seen (10, 29). This appears to 
be due to random segregation of chromosomes. The karyotype 
that  the  hybrids produced by the  fusion  of SAK with dex- 
sensitive W7 cells (Fig. 6A) shows many cells with fewer than 
the  modal  number  of chromosomes.  The  hybrids  obtained 
from this fusion are sensitive to dex.  The fusion can be de- 
scribed as: 
SAK (2r+/21 -)  ×  W7 (2r+/21 +)  ~  hybrid (4r+/21+21-). 
alex-resistant  dex-sensitive  dex-sensitive 
The fact that dex-sensitive hybrids are generated from the 
fusion  of a  dex-sensitive parent  with  a  alex-resistant parent 
indicates that  the  dex-resistant phenotype  is  recessive.  This 
supports the hypothesis that the SAK cells are resistant to dex 
because of the absence of the lysis function and not due to the 
presence of a "protecting" substance. 
Dex-resistant derivatives of the hybrid containing four copies 
of the receptor allele were selected at a frequency on the order 
of 2.5  x  10  -5. Of the six dex-resistant derivatives tested, four 
retained the  full amount  (50,000  to  60,000  sites per cell) of 
glucocorticoid receptor; in all cases, the nuclear transfer of the 
receptor was essentially the same as that of the dex-sensitive 
hybrid parent. 
Fig. 5 shows the growth of the dex-sensitive hybrid, which 
is killed in 10  -'~ M dex, and of one dex-resistant derivative. The 
resistant derivative which still contains 50,900 (+_ 4,300) recep- 
tors/cell  (Fig.  2)  continues  to  grow  in  the  presence  of the 
hormone.  Since  chromosome  segregation  would  provide  a 
likely explanation for the appearance of dex-resistant deriva- 
tives  from  the  dex-sensitive phenotype,  we  determined  the 
number  of chromosomes in  the dex-sensitive hybrid and  its 
dex-resistant derivative. 
The  modal  number  of chromosomes  in  the  dex-sensitive 
hybrid is 80 (Fig. 6A). In the dex-resistant derivative (shown 
in Fig. 5) the modal number of chromosomes has shifted to 78 
(Fig. 6 B). This result is consistent with the idea that the dex- 
resistant  derivative has  segregated  two  chromosomes  which 
carry the genetic information for the "lysis" function involved 
in the response: 
Previous work has shown that fusion of two wild type W7 
parents yielding a hybrid with four copies of the receptor locus 
gave rise to dex-resistant variants with a  frequency of <2.5  x 
10 -s (28).  This  low  t;requency  is expected since  this  hybrid 
would also have four copies of the lysis function. 
In other experiments, dex-resistant derivatives were selected 
using the hybrid which only contains two receptor alleles. In 
this case, segregation of  chromosomes carrying genetic material 
involved in the "lysis" function is not favored (2r+2r-/21+21 -) 
over segregation of chromosomes bearing receptor loci. Pre- 
dictably, 18 out of 21  clones analyzed had -<50% of the hor- 
mone  binding seen in  the  dex-sensitive hybrid parent.  Such 
dex-resistant clones arose at a  frequency on the order of 5 x 
10 -3  ,  two orders of magnitude higher than the  frequency of 
resistance derived from the hybrid tetraploid for the receptor. 
These results are in good agreement with previous studies using 
hybrids of W7 and its derivatives (10, 28). 
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FIGURE  5  Growth  of  sensitive  and  resistant  hybrids  in  dex,  The 
hybrid constructed  from  the fusion of SAK cells with  the W7  cell 
line containing wild type receptor (X) as well as one dex' derivative 
(O)  of  the dex  s hybrid  (receptor assays for  both  shown  in  Fig. 2) 
were grown  in  10  -s  M  dex, and  living  cells  were determined  by 
trypan blue exclusion. 
I0  dex  s  hybrid 
FIGURE  6  Segregation  of 
the  'T'  function.  Meta- 
phase  spreads  were  pre- 
pared as described (4)  and 
the  chromosomes  in  the 
dex  s  hybrid  (A)  and  the 
dex  r  derivative  (B)  were 
cou nted. 
o~ 
o 
I'  dex r  derivative 
(4r+/21 + 21-)  ~  (4r+/21 -) 
dex sensitive  dex resistant  NO.  OF  CHROMOSOMES 
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We have shown that the SAK cell line contains functional 
glucocorticoid receptor and is resistant to lysis by dex due to a 
deficiency in the "lysis" function. The origin of dex resistance 
in  SAK  could  be  a  mutation  in  gene(s)  encoding  the  lysis 
function  or  the  inactivation  of the  lysis gene(s)  through  a 
process such as differentiation. In vivo, mature immunocom- 
petent T-cells are resistant to lysis by glucocorticoids; it seems 
possible that SAK might be an example of this more mature 
dex-resistant T-cell type. If this were the case, one might be 
able to activate the expression of the "lysis" gene(s) in these 
ceils. To distinguish between these possibilities, we have em- 
ployed a technique previously shown to activate silent genes. 
Recently, a  large amount of work from a  number of labo- 
ratories has established a correlation between hypomethylation 
of DNA and expression of specific genes (reviewed in reference 
30). The drug 5-azacytidine inhibits DNA methylation and has 
been shown to cause heritable changes in gene expression in a 
variety of cell lines (26, 31-33). We treated SAK8 ceils with 5- 
azacytidine, allowed them to recover, and subcloned the pop- 
ulation  (as  described in  Materials and  Methods).  Since  the 
incorporation  of 5-azacytidine into  DNA  is  thought  to  be 
random,  it  is  important  to  screen  for  clones  expressing the 
specific function under investigation. 
The subclones were tested for sensitivity to glucocorticoids 
and at least 10% of the individual clones tested were lysed by 
dex. The frequency of dex-sensitive clones was always high but 
varied with the length of the 5-azacytidine treatment and with 
the time after treatment at which the clones were assayed. Fig. 
7  shows the  growth  of SAK8  (Fig. 7A)  and  one  such  dex- 
sensitive clone derived by treatment of SAK8 with 5-azacyti- 
dine (Fig. 7B)  in the presence and  absence of  10  -7 M  dex. 
Thus,  it is possible to "activate" the lysis function in SAK8 
ceils by treatment with 5-azacytidine. To demonstrate that the 
dex-sensitive subclones did not pre-exist in the SAK8 popula- 
tion, SAK8 ceils were subcloned and  100 independent clones 
were  assayed for response to glucocorticoids. All 100  clones 
were dex-resistant. The high frequency at which dex-sensitive 
iAAK8untreoted  sx 
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o  2'o 
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/ 
60  ~;  20  eo 
TIME (hours) 
FIGURE  7  5-azacytidine treatment of SAK8  cells.  SAK8  cells were 
treated with  3 #M  5-azacytidine for 13  h,  allowed to recover, and 
subcloned as described in  Materials and  Methods.  (A)  Untreated 
SAK8 cells grown in the absence (X)  and  presence (O)  of 10  -7 M 
dex. (B) One subclone characterized after azacytidine treatment of 
SAK8 grown  in  the absence (X)  and  presence (O)  of 10  -7  M  dex. 
Living cells were determined by trypan blue exclusion. The dotted 
line  (B)  indicates that  no  living cells were detected; the  limit  of 
detection is 2.2 x  10  3 cells/ml. 
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clones are generated after 5-azacytidine treatment must be as 
a result of the action of the drug on SAK8 cells. 
The generation of dex-sensitive subclones of SAK8 through 
demethylation of DNA supports the hypothesis that the ab- 
sence of the lysis function in SAK8 is not due to a mutation; 
it appears that  the  necessary genetic material is  "intact"  in 
SAK8 but inactivated through DNA methylation. These results 
extend our genetic studies showing that the recessive absence 
of the "lysis" function in SAK is complemented by functional 
lysis locus or loci in W7 ceils. 
DISCUSSION 
To  date,  the  hundreds  of dex-resistant derivatives obtained 
from the murine T-cell lines $49 and W7, as well as the human 
CEM-C7 line, have been shown to be the result of defects in 
the glucocorticoid receptor (reviewed in references 5 and  7). 
Two general types of receptor defects have been characterized: 
(a)  defects  in  receptor quantity  and  (b)  defects in  receptor 
quality, such as nuclear transfer defective. Somatic cell hybrids 
have been used to demonstrate that a  receptor defect of one 
type is not complemented by a different type of receptor defect 
(8,  10). These data are in agreement with recent work showing 
that a  single purified polypeptide is capable of binding both 
glucocorticoid hormones  and  specific DNA  sequences  (34). 
There is no evidence that more than a single protein molecule 
is required to bind glucocorticoid hormones and elicit a  bio- 
logical response. 
SAK cells are resistant to glucocorticoids in spite of the fact 
that by both biological and biochemical criteria they contain 
functional  receptor.  Glucocorticoid  hormones  have  specific 
effects on the growth of SAK cells, as well as on the accumu- 
lation of metallothionein and MuLV mRNAs. The increase in 
MuLV mRNA by glucocorticoids has not been reported pre- 
viously. 
The studies described here provide the first genetic evidence 
for a function, other than the glucocorticoid receptor, involved 
in  the cytolytic response.  The  glucocorticoid receptor of the 
SAK  cell line  complements  the  receptor-defective W7  line, 
resulting in a dex-sensitive hybrid. No increase over the sum of 
the parental hormone binding sites is seen in the hybrid, which 
rules  out  an  "activation"  of the  defective  receptor  of W7. 
Therefore, the basis for glucocorticoid resistance in SAK cells 
must be in another function which may be determined by a 
single genetic locus or several loci. 
The hybrid between the dex-resistant SAK cells and the dex- 
sensitive W7 cell line is dex sensitive. In this fusion the dex- 
resistant phenotype is recessive. If SAK cells are not resistant 
due  to  a  defect in  the  lysis function  and  instead produce a 
substance that "protects" the ceils from lysis, one would have 
expected the resistant phenotype to be dominant unless this 
substance  is present  in  limiting amounts  such  that  it is  not 
produced in a sufficient quantity to "protect" a tetraploid cell. 
This possibility seems unlikely since it is possible to "activate" 
the lysis function in  SAK8 by treatment with  5-azacytidine. 
Although one could argue that 5-azacytidine activates an in- 
hibitor of the  "protecting"  substance,  this  is  a  much  more 
complicated model introducing additional and speculative as- 
sumptions. 
We have used two different hybrids, one  diploid and  the 
other tetraploid for the receptor locus, to select dex-resistant 
derivatives. It is possible to generate resistance through the loss 
of receptor as well as through the loss of nonreceptor genetic 
material involved in the lysis response, depending on the ploidy of the receptor locus.  The  hybrid tetraploid for the receptor 
locus became dex-resistant through the segregation of only two 
chromosomes, on the average, without loss of receptor. We are 
currently constructing imerspecies hybrids to perform similar 
experiments designed to map the "lysis" gene(s) to a  specific 
chromosome. 
It is interesting to examine the means by which SAK8 cells 
may have acquired glucocorticoid resistance. We used 5-aza- 
cytidine to inhibit DNA methylation in SAK8 cells and gen- 
erated dex-sensitive derivatives. Work from several laboratories 
has demonstrated that thymidine kinase (33),  viral (35),  and 
metallothionein genes (26)  can be activated by treatment of 
cells with  5-azacytidine. It appears, therefore,  that  the  SAK 
line is derived from a mature dex-resistant thymocyte and that, 
during differentiation, nonreceptor gene(s) involved in the lytic 
response  is/are  inactivated  through  methylation  of specific 
DNA sites. If so, immature thymocytes may become resistant 
to  glucocorticoids  through  the  inactivation  of  nonreceptor 
genes involved in the lytic response; the glucocorticoid receptor 
would still be expressed and capable of mediating other effects 
of glucocorticoid hormones on the metabolic processes of these 
cells. The type of glucocorticoid resistance attained by meth- 
ylation of DNA would have an epigenetic origin since it would 
involve a  modification rather than  a  change  in the  base se- 
quence of the DNA. In contrast, the variety of receptor-defec- 
tive variants generated from W7 and $49  cell lines by muta- 
genic treatments  (5)  appear to  be  the  result  of rare  genetic 
(mutational) events. 
The demonstration of a function other than the glucocorti- 
cold  receptor  involved  in  cytolysis raises  several  questions 
about the nature of this "lysis" function. It is certainly possible 
that hormone-induced cell death is the result of a cascade of 
events,  only  one  of which  needs  to  be  inactive to  generate 
resistance such as that seen in SAK cells. It may be possible, in 
the future, to identify defects in several loci, any one of which 
is sufficient to confer glucocorticoid resistance. Clearly, in the 
case  of SAK  cells,  the  "defect"  resulting  in  dex  resistance 
cannot  be in a  vital function since one would expect such a 
defect to be lethal. Finally, it remains to be determined whether 
the "lysis" genes are induced directly by dex or indirectly by 
means of one or several protein intermediates. Another possi- 
bility is that the glucocorticoid hormone receptor interacts with 
a  constitutively expressed  "acceptor"  protein specifically re- 
quired for the lytic response, and that the two proteins together 
are required to induce the cytolysis. In that case, this "acceptor" 
would be the "lysis" function absent in SAK8 cells. 
It  is  certainly  of interest  to  determine  whether  a  "lysis" 
function is also involved in the lytic response of human T-cell 
lines, and whether this epigenetic mode of the acquisition of 
resistance  also  applies  to  human  T-cell  maturation.  These 
questions are currently being examined in human cell lines and 
could have implications in the treatment of human leukemias 
and lymphomas. 
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